Britannia Life Sciences Inc

Recent News

Miraculins Provides Update on Strategic Review Process

Winnipeg, Manitoba--(Newsfile Corp. - February 24, 2016) - Miraculins Inc. (TSXV: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today that pursuant to the strategic review process the Company has been undertaking, it will retain ownership of its Scout DS® lead technology. The Company also announces that it has made changes to its business plan and...

2016-02-24 8:30 AM EST

Miraculins Announces Secured Loan

Winnipeg, Manitoba--(Newsfile Corp. - February 17, 2016) - Miraculins Inc. (TSXV: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces that it has arranged a secured loan (the "Loan") totaling $100,000, with Bradstone Capital Corp. (the "Lender"), a company with an officer who is also an officer of the Company. The Loan shall mature the earlier of i)...

2016-02-17 8:16 AM EST

Miraculins Appoints Ashwath Mehra to the Board of Directors

Winnipeg, Manitoba--(Newsfile Corp. - February 9, 2016) - Miraculins Inc. (TSXV: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs announces today, the appointment of Mr. Ashwath Mehra to the Company's Board of Directors. Mr. Mehra holds a BSc (Econ) from the London School of Economics and is currently the CEO of the Astor Group, an investment and advisory group of...

2016-02-09 7:00 AM EST

Miraculins Announces the Appointment of Chris Carmichael as Chief Financial Officer

Winnipeg, Manitoba--(Newsfile Corp. - January 18, 2016) - Miraculins Inc. (TSXV: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs announces that effective today, Mr. Christopher Carmichael, CPA, CGA, has been appointed Chief Financial Officer (CFO) of the Company. Mr. Carmichael replaces Mr. James Kinley, who has served as CFO since December 23, 2011 under a...

2016-01-18 8:02 AM EST

IIROC Trade Resumption - Miraculins Inc.

Vancouver, British Columbia--(Newsfile Corp. - December 24, 2014) - Trading resumes in: Company: Miraculins Inc.

2014-12-24 7:56 AM EST

IIROC Trade Halt - Miraculins Inc.

Vancouver, British Columbia--(Newsfile Corp. - December 23, 2014) - The following issues have been halted by IIROC: Company:

2014-12-23 3:34 PM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us